Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway.
about
Anti-platelet therapy: phosphodiesterase inhibitors.Mechanisms of Amplified Arteriogenesis in Collateral Artery Segments Exposed to Reversed Flow Direction.Nitrite anion stimulates ischemic arteriogenesis involving NO metabolism.The neuron-astrocyte-microglia triad in a rat model of chronic cerebral hypoperfusion: protective effect of dipyridamole.Identification of the ENT1 antagonists dipyridamole and dilazep as amplifiers of oncolytic herpes simplex virus-1 replicationNitrite anion therapy protects against chronic ischemic tissue injury in db/db diabetic mice in a NO/VEGF-dependent manner.Inorganic nitrite and chronic tissue ischaemia: a novel therapeutic modality for peripheral vascular diseases.PKA turnover by the REGγ-proteasome modulates FoxO1 cellular activity and VEGF-induced angiogenesis.Grb-2-associated binder 1 (Gab1) regulates postnatal ischemic and VEGF-induced angiogenesis through the protein kinase A-endothelial NOS pathway.Control of angiogenesis dictated by picomolar superoxide levels.Dipyridamole reverses peripheral ischemia and induces angiogenesis in the Db/Db diabetic mouse hind-limb model by decreasing oxidative stress.Inorganic nitrite therapy: historical perspective and future directions.Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing.Nitrite and nitric oxide metabolism in peripheral artery disease.Emerging role of PKA/eNOS pathway in therapeutic angiogenesis for ischaemic tissue diseasesHigh-throughput screening for bioactive molecules using primary cell culture of transgenic zebrafish embryos.Targeting phosphodiesterases in anti-platelet therapyPlasma free H2S levels are elevated in patients with cardiovascular disease.Nucleoside reverse transcriptase inhibitors induce a mitophagy-associated endothelial cytotoxicity that is reversed by coenzyme Q10 cotreatment.Nitrite activates protein kinase A in normoxia to mediate mitochondrial fusion and tolerance to ischaemia/reperfusion.Reperfusion of chronic tissue ischemia: nitrite and dipyridamole regulation of innate immune responses.Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke.Nitric Oxide and Hydrogen Sulfide Regulation of Ischemic Vascular Remodeling.Heart-rate reduction by If-channel inhibition with ivabradine restores collateral artery growth in hypercholesterolemic atherosclerosis.Genetic background determines inflammatory angiogenesis response to dipyridamole in mice.The Japanese aggrenox (extended-release dipyridamole plus aspirin) stroke prevention versus aspirin programme (JASAP) study: a randomized, double-blind, controlled trial.Genetic strain differences in the development of peritoneal fibroproliferative processes in mice.
P2860
Q27687228-27F7D76B-8A0C-42AB-8729-7D997BA0546CQ30278752-7040574A-034F-480D-BEEC-855A6F6405D8Q30522302-9D1AF918-B62C-49CB-8110-F2E9B6879D1AQ30602337-BB98CD30-CC71-4FCF-AD04-E171C5804981Q33566587-D88547A8-17F7-43E2-9EE5-5FD0E3ACB6E2Q34263955-3FDA778A-80FB-404D-863C-AB63DAD31736Q34530182-8B1D581F-0D8E-4D9C-ADD0-D551486F54B8Q34541955-64B4C6B8-6575-4CE2-B4A4-DA9174A20433Q34582584-105F35C1-38C9-457F-99D7-31A34F7BBC4CQ34727974-4E3C7026-CBC8-4374-BE84-A3F61F552D0EQ35551211-5B9EBB8C-E4EB-41C1-A12E-0715A7FC6975Q35552149-F42A7DFB-4A13-4F35-A34B-1A26A021FCB8Q35947546-D86A6D55-469B-4E8F-829C-83B16DCA3331Q35989648-136F7EBE-9080-47FB-9D40-0B541D2FC6F0Q36042713-76F167F0-7980-4BD2-89B7-BFA3DF077AF7Q36291384-E3A9AE87-4A31-4983-A7BE-9A22AB80AE6EQ36929627-5835D1F6-0CDD-4B33-B84F-DF9E5FAACC89Q37328808-185C8B97-15D1-4E06-8F8F-990A8FB6178AQ37346797-D56498B0-15CF-4FE1-9F03-D4CF9AAB6FDFQ37404168-D7C7EA67-EA96-4C82-93D7-CA3D0CBBD9CAQ37800992-ABEA8928-2D2B-49DC-A97F-ADAB98BBEFC1Q37971308-B29F836F-5369-44FE-87FF-9DC1C22D455AQ38588632-C3D4AC65-DBFA-4021-A83F-E44E5812D85EQ42728143-5786A3A3-FE9C-4DD7-8569-E4E04DE8D71DQ43858856-AE604468-8371-459E-A908-7B802CB9FD74Q45861292-D59995D7-DEC2-4222-9C2C-D262D09386CAQ46892257-4817D0CA-F609-4C4C-A168-63553386D01C
P2860
Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Dipyridamole enhances ischaemi ...... itric oxide-dependent pathway.
@ast
Dipyridamole enhances ischaemi ...... itric oxide-dependent pathway.
@en
Dipyridamole enhances ischaemi ...... itric oxide-dependent pathway.
@nl
type
label
Dipyridamole enhances ischaemi ...... itric oxide-dependent pathway.
@ast
Dipyridamole enhances ischaemi ...... itric oxide-dependent pathway.
@en
Dipyridamole enhances ischaemi ...... itric oxide-dependent pathway.
@nl
prefLabel
Dipyridamole enhances ischaemi ...... itric oxide-dependent pathway.
@ast
Dipyridamole enhances ischaemi ...... itric oxide-dependent pathway.
@en
Dipyridamole enhances ischaemi ...... itric oxide-dependent pathway.
@nl
P2093
P2860
P356
P1476
Dipyridamole enhances ischaemi ...... itric oxide-dependent pathway.
@en
P2093
Billy Branch
Christopher B Pattillo
Christopher G Kevil
Prasanna K Venkatesh
Sandra Illum
Sibile Pardue
Steven Thoma
Xinjun Teng
P2860
P304
P356
10.1093/CVR/CVQ002
P577
2010-01-08T00:00:00Z